Читать книгу Assisted Reproduction Techniques - Группа авторов - Страница 162

1 1 Shah S, Verma P. Overview of pregnancy in renal transplant patients. International Journal of Nephrology 2016, Article ID 4539342.

2 2 Matuszkiewicz‐Rowinska J, Skorzewska K S. Radowicki S et al., Endometrial morphology and pituitary‐gonadal axis dysfunction in women of reproductive age undergoing chronic haemodialysis—a multicentre study. Nephrology Dialysis Transplantation. 2004; 19(8):2074–2077.

3 3 Weisinger JR, Bellorin‐Font E. Outcomes associated with hypogonadism in women with chronic kidney disease. Advances in Chronic Kidney Disease. 2004; 11(4):361–370.

4 4 Bagon JA, Vernaeve H, De M, X, Lafontaine JJ, Martens J, Van RG. Pregnancy and dialysis. Am J Kidney Dis 1998; 31(5):756–765.

5 5 Giatras I, Levy DP, Malone FD, Carlson JA, Jungers P. Pregnancy during dialysis: case report and management guidelines. Nephrology Dialysis Transplantation. 1998; 13(12):3266–3272.

6 6 Piccoli GB, Conijn A, Consiglio V, Vasario E, Attini R, Deagostini MC et al. Pregnancy in dialysis patients: is the evidence strong enough to lead us to change our counseling policy? Clin J Am Soc Nephrol 2010; 5(1):62–71.

7 7 Saha MT, Saha HHT, Niskanen LK, Salmela KT, Pasternack AI. Time course of serum prolactin and sex hormones following successful renal transplantation. Nephron 2002; 92(3):735–737.

8 8 Anantharaman P, Schmidt RJ. Sexual function in chronic kidney disease. Adv Chronic Kidney Dis 2007; 14(2):119–125.

9 9 Lim VS, Henriquez C, Sievertsen G, Frohman LA. Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation. Ann Intern Med 1980; 93(1):21–27.

10 10 Kim HW, Seok HJ, Kim TH, Han DJ, Yang WS, Park SK. The experience of pregnancy after renal transplantation: pregnancies even within postoperative 1 year may be tolerable. Transplantation 2008; 85(10):1412–1419.

11 11 Levidiotis V, Chang S, McDonald S. Pregnancy and maternal outcomes among kidney transplant recipients. J Am Soc Nephrol 2009; 20(11):2433–2440.

12 12 Armenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF. National Transplantation Pregnancy Registry—outcomes of 154 pregnancies in cyclosporine‐treated female kidney transplant recipients. Transplantation 1994; 57(4):502–506.

13 13 Norrman E, Bergh C, Wennerholm UB, Pregnancy outcome and long‐term follow‐up after in vitro fertilization in women with renal transplantation, Human Reproduction 2015; 30(1):205–213

14 14 Yaprak M, Doğru V, Sanhal CY, Özgür K, Erman M. In vitro fertilization after renal transplantation: a single‐center experience. Transplant Proc. 2019; 51(4):1089–1092.

15 15 Warzecha D, Szymusik I, Grzechocińska B, Cyganek A, Kociszewska‐Najman B, Mazanowska N, Madej A, Pazik J, Wielgoś M, Pietrzak B. In vitro fertilization and pregnancy outcomes among patients after kidney transplantation: case series and single‐center experience. Transplant Proc. 2018; 50(6):1892–1895.

16 16 Khalaf Y, Elkington N, Anderson H, Taylor A, Braude P. Ovarian hyperstimulation syndrome and its effect on renal function in a renal transplant patient undergoing IVF treatment: case report. Hum Reprod 2000; 15(6):1275–1277.

17 17 Stanley CW, Gottlieb R, Zager R, Eisenberg J, Richmond R, Moritz MJ et al. Developmental well‐being in offspring of women receiving cyclosporine post‐renal transplant. Transplant Proc 1999; 31(1‐2):241–242.

18 18 Chambers CD, Braddock SR, Briggs GG et al. Postmarketing surveillance for human teratogenicity: a model approach. Teratology 2001; 64(5): 252–261

19 19 Venkataramanan R, Koneru B, Wang CCP, Burckart GJ, Caritis SN, Starzl TE. Cyclosporine and its metabolites in mother and baby. Transplantation 1988; 46(3): 468–469.

20 20 Coscia LA, Constantinescu S, Moritz MJ et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clinical Transplants 2010; 65–85.

21 21 Scott JR, Branch DW, Holman J. Autoimmune and pregnancy complications in the daughter of a kidney transplant patient. Transplantation 2002; 73(5):815–816.

22 22 Sgro MD, Barozzino T, Mirghani HM, Sermer M, Moscato L, Akoury H et al. Pregnancy outcome post renal transplantation. Teratology 2002; 65(1):5–9.

23 23 Stanley CW, Gottlieb R, Zager R et al. Developmental wellbeing in offspring of women receiving cyclosporine post‐renal transplant. Transplantation Proceedings 1999; 31(1‐2):, 241–242.

24 24 Day C, Hewins P, Sheikh L, Kilby M, McPake D, Lipkin G. Cholestasis in pregnancy associated with ciclosporin therapy in renal transplant recipients. Transpl Int 2006; 19(12):1026–1029.

25 25 Saarikoski S, Seppal M. Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. American Journal of Obstetrics and Gynecology 1973; 115(8): 1100–1106.

26 26 Chhabria S. Aicardi’s syndrome: are corticosteroids teratogens? Archives of Neurology 1981; 38(70).

27 27 Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti T. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 2006; 82(12):1698– 1702.

28 28 Jones A, Clary MJ, McDermott E et al. Outcomes of pregnancies fathered by solid‐organ transplant recipients exposed to mycophenolic acid products. Progress in Transplantation 2013; 23(2): 153–157.

29 29 Bramham K, Nelson‐Piercy C, Gao H et al. Pregnancy in renal transplant recipients: a UK national cohort study. Clinical Journal of the American Society of Nephrology 2013; 8(2): 290–298.

30 30 Duley L, Henderson‐Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre‐eclampsia and its complications. Cochrane Database of Systematic Reviews, no. 2, Article ID CD004659, 2007.

31 31 Davison JM, Lind T, Uldall PR. Planned pregnancy in a renal transplant recipient. Br J Obstet Gynaecol 1976; 83(7):518–527.

32 32 European best practice guidelines for renal transplantation. Section IV: long‐term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipient. EBPG Expert Group on Renal Transplantation, vol. 17, supplement 4, pp. 50– 55, 2002.

33 33 McKay DB, Josephson MA, Armenti VT, August P, Coscia LA, Davis CL et al. Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant 2005; 5(7):1592–1599.

34 34 Youssef MAFM, Veen F, Al‐Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, et al. Gonadotropin‐releasing hormone agonist versus HCG for oocyte triggering in antagonist‐assisted reproductive technology. Cochrane Database of Systematic Reviews 2014, Issue 10.

35 35 Tang H, Hunter T, Hu Y, Zhai SD, Sheng X, Hart RJ. Cabergoline for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD008605.